Why UK Employers Need a Medical Cannabis Policy
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use and will improvise…’
Explainers and foundations for understanding cannabis medicine from the ground up.
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use and will improvise…’
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological […]
An expert explains everything you need to know about the entourage effect.
Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to find the right dose.
Explore the reported benefits, the latest research and where you can find it.
The terms ‘indica’ and ‘sativa’ have been widely used to categorise cannabis products, but do these labels really matter?
The ‘legal high’ Hexahydrocannabinol, better known as HHC, is on the rise across Europe. Here’s what you need to know.
An expert answers some frequently asked questions about the use of cannabis in paediatric epilepsy.
A UK cannabis prescriber shares what he has learned on his journey so far.
In a new series a UK cannabis prescriber shares what he has learned on his journey so far.
What the science says about cannabis, sex, love and intimacy.
Vaporisation is one of the most common cannabis consumption methods, but what do we know about the potential risks?
Upcoming Symposiums
Evidence-led education for clinicians, industry and patient advocates — across Europe.
See all events4 November 2026
Frankfurt · Mainhaus
26 November 2026
London · Conway Hall